We have previously reported an association between the site of first metastases and ER status. ER positive patients preferentially metastasise to bone (Campbell et al., 1981) . We suggest that this early finding of a relationship between disease-free interval and ER status, before stratification according to node positivity, may in part be due to the consistently short disease-free interval in those patients presenting with visceral metastases associated with ER Blamey et al. (1980) find that in patients with node involvement oestrogen receptor positive tumours carry a better prognosis than receptor negative, whereas we do not find such a difference in the different subsets of the patients we studied including node negative cases. However, the data of Blamey et al. (1980) and Campbell et al. (1981) completely agree with ours in that, overall, patients with oestrogen receptor positive tumours fare no better in terms of disease-free interval than do patients with receptor negative tumours. We cannot understand the difference concerning this point in the letter of Dr Williams and the paper of Blamey et al. (1980) , to which he refers. We also observe with satisfaction that in the case of progesterone receptor and disease-free interval no difference seems to prevail between the data of Griffiths et al. (1983) and those of ourselves.
Our data on associations between oestrogen and progesterone receptors and some other parameters of breast cancer including site of first metastasis will appear in the near future (Alanko et al., 1985 
